User profiles for S. Knight

Shandra Lee Knight

- Verified email at njhealth.org - Cited by 30477

Stephen R Knight

- Verified email at doctors.org.uk - Cited by 14883

Mechanisms of action of probiotics: recent advances

…, MA Kamm, AJ Stagg, SC Knight - Inflammatory bowel …, 2009 - academic.oup.com
The intestinal microbiota plays a fundamental role in maintaining immune homeostasis. In
controlled clinical trials probiotic bacteria have demonstrated a benefit in treating …

Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper

…, AG Nicholson, SL Knight, S Raoof… - The Lancet respiratory …, 2018 - thelancet.com
This Review provides an updated approach to the diagnosis of idiopathic pulmonary fibrosis
(IPF), based on a systematic search of the medical literature and the expert opinion of …

[HTML][HTML] Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer

…, N English, SK Clark, AL Hart, SC Knight… - World journal of …, 2016 - ncbi.nlm.nih.gov
Inflammatory bowel diseases are characterised by inflammation that compromises the
integrity of the epithelial barrier. The intestinal epithelium is not only a static barrier but has …

[PDF][PDF] SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses

…, PW Horby, S Ijaz, S Khoo, A Law, MR Lewis, S Liggi… - Cell, 2022 - cell.com
On 24 th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529
was announced, containing far more mutations in Spike (S) than previously reported …

Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline

…, EA Kazerooni, M Kitaichi, SL Knight… - American journal of …, 2018 - atsjournals.org
Background: This document provides clinical recommendations for the diagnosis of
idiopathic pulmonary fibrosis (IPF). It represents a collaborative effort between the American …

Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America …

…, GW Waterer, P Cruse, SL Knight… - Clinical infectious …, 2016 - academic.oup.com
… In patients with suspected VAP, we recommend including coverage for S. aureus,
Pseudomonas aeruginosa, and other gram-negative bacilli in all empiric regimens (strong …

Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline

…, M Selman, T Ewing, S Jones, SL Knight… - American Journal of …, 2022 - atsjournals.org
… The systematic review that informed the committee’s recommendation is published
independently (76); we summarize the salient findings. Diagnostic test characteristics were rated as …

Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C …

SR Knight, A Ho, R Pius, I Buchan, G Carson… - bmj, 2020 - bmj.com
Objective To develop and validate a pragmatic risk score to predict mortality in patients admitted
to hospital with coronavirus disease 2019 (covid-19). Design Prospective observational …

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

…, J van Beynen, NR English, SC Knight… - The Journal of …, 2001 - journals.aai.org
Defective dendritic cell (DC) function caused by abnormal differentiation of these cells is an
important mechanism of tumor escape from immune system control. Previously, we have …

X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions

…, SW Knight, TJ Vulliamy, SM Klauck, S Wiemann… - Nature …, 1998 - nature.com
X-linked recessive dyskeratosis congenita (DKC) is a rare bone-marrow failure disorder linked
to Xq28. Hybridization screening with 28 candidate cDNAs resulted in the detection of a 3…